BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 11507067)

  • 1. Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model.
    Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Yamaue H; Tanimura H
    Cancer Res; 2001 Aug; 61(16):6158-62. PubMed ID: 11507067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of carcinoembryonic antigen-specific prodrug gene therapy for experimental colon cancer.
    Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Ojima T; Yamaue H
    Surgery; 2003 Mar; 133(3):309-17. PubMed ID: 12660644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo selective gene expression and therapy mediated by adenoviral vectors for human carcinoembryonic antigen-producing gastric carcinoma.
    Lan KH; Kanai F; Shiratori Y; Ohashi M; Tanaka T; Okudaira T; Yoshida Y; Hamada H; Omata M
    Cancer Res; 1997 Oct; 57(19):4279-84. PubMed ID: 9331089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific chemo-radio-gene therapy for colorectal cancer cells using adenovirus vector expressing the cytosine deaminase gene.
    Ueno M; Koyama F; Yamada Y; Fujimoto H; Takayama T; Kamada K; Naito A; Hirao S; Mukogawa T; Hamada H; Nakajima Y
    Anticancer Res; 2001; 21(4A):2601-8. PubMed ID: 11724328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective and safe gene therapy for colorectal carcinoma using the cytosine deaminase gene directed by the carcinoembryonic antigen promoter.
    Cao G; Kuriyama S; Gao J; Kikukawa M; Cui L; Nakatani T; Zhang X; Tsujinoue H; Pan X; Fukui H; Qi Z
    Gene Ther; 1999 Jan; 6(1):83-90. PubMed ID: 10341879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer.
    Kijima T; Osaki T; Nishino K; Kumagai T; Funakoshi T; Goto H; Tachibana I; Tanio Y; Kishimoto T
    Cancer Res; 1999 Oct; 59(19):4906-11. PubMed ID: 10519403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental study on human pancreatic carcinoma treated by cytosine deaminase gene therapy].
    Zhang S; Yuan S
    Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):249-51. PubMed ID: 11798763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
    Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
    Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
    Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY
    Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor.
    Manome Y; Watanabe M; Abe T; Tomita M; Watanabe S; Yokokawa Y; Takahashi Y; Ishii K; Kimura A; Murakami M; Nagata M; Shibata T; Nakamura M; Tanigawa N; Ohno T
    Anticancer Res; 2001; 21(4A):2265-72. PubMed ID: 11724281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice.
    Gnant MF; Puhlmann M; Alexander HR; Bartlett DL
    Cancer Res; 1999 Jul; 59(14):3396-403. PubMed ID: 10416601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced selective gene expression by adenovirus vector using Cre/loxP regulation system for human carcinoembryonic antigen-producing carcinoma.
    Ueda K; Iwahashi M; Nakamori M; Nakamura M; Yamaue H; Tanimura H
    Oncology; 2000 Sep; 59(3):255-65. PubMed ID: 11053994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoviral oncolytic suicide gene therapy for a peritoneal dissemination model of gastric cancer in mice.
    Imamura Y; Ishikawa S; Sato N; Karashima R; Hirashima K; Hiyoshi Y; Nagai Y; Koga Y; Hayashi N; Watanabe M; Yamada G; Baba H
    Ann Surg Oncol; 2010 Feb; 17(2):643-52. PubMed ID: 20012217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine.
    Koyama F; Sawada H; Hirao T; Fujii H; Hamada H; Nakano H
    Cancer Gene Ther; 2000 Jul; 7(7):1015-22. PubMed ID: 10917204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy.
    Xie Y; Gilbert JD; Kim JH; Freytag SO
    Clin Cancer Res; 1999 Dec; 5(12):4224-32. PubMed ID: 10632364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the human carcinoembryonic antigen promoter core region in colorectal carcinoma-selective cytosine deaminase gene therapy.
    Cao G; Kuriyama S; Cui L; Nagao S; Pan X; Toyokawa Y; Zhang X; Nishiwaki I; Qi Z
    Cancer Gene Ther; 1999; 6(6):572-80. PubMed ID: 10608354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approach.
    Anderson LM; Krotz S; Weitzman SA; Thimmapaya B
    Cancer Gene Ther; 2000 Jun; 7(6):845-52. PubMed ID: 10880014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of repeated direct intratumoral gene transfer using hemagglutinating virus of Japan-liposome method for cytosine deaminase suicide gene therapy.
    Kanyama H; Tomita N; Yamano T; Aihara T; Miyoshi Y; Ohue M; Sekimoto M; Sakita I; Tamaki Y; Kaneda Y; Senter PD; Monden M
    Cancer Res; 2001 Jan; 61(1):14-8. PubMed ID: 11196152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.
    Peng XY; Won JH; Rutherford T; Fujii T; Zelterman D; Pizzorno G; Sapi E; Leavitt J; Kacinski B; Crystal R; Schwartz P; Deisseroth A
    Cancer Res; 2001 Jun; 61(11):4405-13. PubMed ID: 11389068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme/prodrug gene therapy for human colon cancer cells using adenovirus-mediated transfer of the Escherichia coli cytosine deaminase gene driven by a CAG promoter associated with 5-fluorocytosine administration.
    Koyama F; Sawada H; Fujii H; Hirao T; Ueno M; Hamada H; Nakano H
    J Exp Clin Cancer Res; 2000 Mar; 19(1):75-80. PubMed ID: 10840940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.